CanadaCefazolin for Injection, USP (Fresenius Kabi Canada Ltd.; DIN 02401029; powder for solution, 100 g per bag), lots 40228 00125 and 40228 00135, are packaged with incorrect linear barcodes on inner and outer bag labels. The product was recalled because those lots have incorrect linear barcodes; verify whether your product is one of the listed lots, consult your healthcare provider before discontinuing use, contact Fresenius Kabi Canada Ltd. with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: FRESENIUS KABI CANADA LTD, 165 Galaxy Blvd, Suite 100, Toronto, ON M9W 0C8.
How to identify it
Brand: FRESENIUS KABI CANADA LTD; Product Name: Cefazolin for Injection,USP; Market Authorization: DIN 02401029; Dosage Form: Powder for Solution; Strength: 100 G / BAG; Lot numbers: 40228 00125, 40228 00135
The hazard
Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)